Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 330 clinical trials
Optimizing Cimzia in Crohn's Patients

moderate to severe Crohn's disease.

certolizumab pegol
cimzia
  • 60 views
  • 08 Nov, 2020
  • 1 location
Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis

The primary purpose of this study is to compare the efficacy of enteral nutrition compared to steroids in inducing remission of active pediatric Crohn’s disease. The main hypothesis of this study is that the use of enteral nutrition induces mucosal healing, whereas steroids do not. This effect may be related …

pediatric onset crohn's disease
remission
enteral nutrition
  • 51 views
  • 07 Nov, 2020
  • 1 location
Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease

beta carotene from Dunaliella may prevent exacerbations of Crohn's disease.

crohn's disease in remission
remission
vitamin
  • 17 views
  • 07 Nov, 2020
  • 1 location
Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease

This study will compare two current first-line treatments for childhood Crohn's Disease, steroids versus a liquid diet, and determine the effects of these treatments on bone health

  • 33 views
  • 07 Nov, 2020
  • 2 locations
Evaluation of PET CT in the Management of Patients With Crohn's Disease.

18F-FDG PET/CT (2-[fluorine-18] fluoro-2-deoxy-D-glucose, Positron emission tomography- CT) is a noninvasive technique that allows quantifying and precisely localizing 18F-FDG uptake in the entire body. 18F-FDG uptake is caused by increased local metabolic activity. Such increased uptake has been described not only in neoplastic lesions but also in inflammatory lesions. In …

tumor necrosis factor alpha
inflammatory bowel disease
remission
tumor necrosis factor
tumour necrosis
  • 15 views
  • 07 Nov, 2020
  • 1 location
Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot Study

treatment of active Crohn's disease as shown by the Harvey-Bradshaw Index (HBI) and/or elevated C-reactive protein (CRP). We hypothesize pravastatin will significantly reduce symptoms of Crohn's

mercaptopurine
methotrexate
azathioprine
mesalamine
budesonide
  • 21 views
  • 07 Nov, 2020
  • 1 location
Postoperative Progression of the Disease Following Extensive Versus Limited Mesenteric Excision for Crohn's Disease

mesenteric excision (LME), in patients undergoing ileocolic resection for Crohn's disease. Half of participants will receive EME, while the other half will receive LME.

  • 0 views
  • 23 Jan, 2021
  • 1 location
Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients

Purpose There is no previous contrast enhanced ultrasound (CEUS) study for pediatric Crohn disease patients. There are adult studies which included adolescent

  • 0 views
  • 27 Jan, 2021
  • 1 location
A Double Blind Placebo Control Study to Assess the Safety Tolerability and Efficacy of Copaxone in Crohn's Disease

phase 2 study. Target disease: Crohn's disease. Rational and relevance to IBD patients: Copaxone is known for its high safety profile and for acting as an effective

corticosteroids
prednisone
antibiotic therapy
tumor necrosis factor alpha
colitis
  • 20 views
  • 07 Nov, 2020
  • 1 location
MILESTONE-CD -A Prospective Multiomic Inception Real -Life Study To Evaluate Predictors of Disease Outcomes & respoNse to Biologic Treatment in Crohn's Disease

Crohn's' disease (CD) is a lifelong-chronic inflammatory condition of the digestive tract. CD frequently manifests during the 2nd or 3rd decade; prolonged disease duration frequently results in

  • 0 views
  • 28 Mar, 2021
  • 1 location